{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,28]],"date-time":"2025-05-28T04:22:38Z","timestamp":1748406158372,"version":"3.41.0"},"reference-count":15,"publisher":"FapUNIFESP (SciELO)","issue":"7","license":[{"start":{"date-parts":[[2015,7,1]],"date-time":"2015-07-01T00:00:00Z","timestamp":1435708800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2015,7,1]],"date-time":"2015-07-01T00:00:00Z","timestamp":1435708800000},"content-version":"am","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2015,7,1]],"date-time":"2015-07-01T00:00:00Z","timestamp":1435708800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Braz J Med Biol Res"],"DOI":"10.1590\/1414-431x20154557","type":"journal-article","created":{"date-parts":[[2015,5,25]],"date-time":"2015-05-25T05:31:42Z","timestamp":1432531902000},"page":"583-587","source":"Crossref","is-referenced-by-count":4,"title":["Evaluation of a father and son with atypical chronic myeloid leukemia with SETBP1 mutations and a review of the literature"],"prefix":"10.1590","volume":"48","author":[{"given":"L.","family":"Wang","sequence":"first","affiliation":[{"name":"Huazhong University of Science and Technology, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Du","sequence":"additional","affiliation":[{"name":"Huazhong University of Science and Technology, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.-M.","family":"Zhang","sequence":"additional","affiliation":[{"name":"Huazhong University of Science and Technology, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.-X.","family":"Wang","sequence":"additional","affiliation":[{"name":"Huazhong University of Science and Technology, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"530","published-online":{"date-parts":[[2015,7]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1182\/blood-2009-03-209262","article-title":"The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes","volume":"114","author":"Vardiman JW","year":"2009","journal-title":"Blood"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1038\/ng.2495","article-title":"Recurrent SETBP1 mutations in atypical chronic myeloid leukemia","volume":"45","author":"Piazza R","year":"2013","journal-title":"Nat Genet"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1056\/NEJMoa1214514","article-title":"Oncogenic CSF3R mutations in chronic neutrophilic leukemia and atypical CML","volume":"368","author":"Maxson JE","year":"2013","journal-title":"N Engl J Med"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1038\/leu.2013.122","article-title":"CSF3R T618I is a highly prevalent and specific mutation in chronic neutrophilic leukemia","volume":"27","author":"Pardanani A","year":"2013","journal-title":"Leukemia"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1002\/ajh.23667","article-title":"Chronic neutrophilic leukemia 2014: Update on diagnosis, molecular genetics, and management","volume":"89","author":"Elliott MA","year":"2014","journal-title":"Am J Hematol"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1097\/MOH.0000000000000114","article-title":"Chronic neutrophilic leukemia: novel mutations and their impact on clinical practice","volume":"22","author":"Tefferi A","year":"2015","journal-title":"Curr Opin Hematol"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1159\/000094684","article-title":"Atypical chronic myeloid leukaemia with CD117-positive blast cells treated with imatinib: A report of two cases","volume":"116","author":"Breccia M","year":"2006","journal-title":"Acta Haematol"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1038\/ng.581","article-title":"De novo mutations of SETBP1 cause Schinzel-Giedion syndrome","volume":"42","author":"Hoischen A","year":"2010","journal-title":"Nat Genet"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1038\/leu.2013.35","article-title":"SETBP1 mutations in 658 patients with myelodysplastic syndromes, chronic myelomonocytic leukemia and secondary acute myeloid leukemias","volume":"27","author":"Damm F","year":"2013","journal-title":"Leukemia"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.1038\/leu.2013.97","article-title":"SETBP1 mutations in 415 patients with primary myelofibrosis or chronic myelomonocytic leukemia: independent prognostic impact in CMML","volume":"27","author":"Laborde RR","year":"2013","journal-title":"Leukemia"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"2072","DOI":"10.1038\/leu.2013.145","article-title":"SETBP1 mutation analysis in 944 patients with MDS and AML","volume":"27","author":"Thol F","year":"2013","journal-title":"Leukemia"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.1038\/leu.2013.133","article-title":"SETBP1 mutations occur in 9% of MDS\/MPN and in 4% of MPN cases and are strongly associated with atypical CML, monosomy 7, isochromosome i(17)(q10), ASXL1 and CBL mutations","volume":"27","author":"Meggendorfer M","year":"2013","journal-title":"Leukemia"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1038\/ng.2696","article-title":"Somatic SETBP1 mutations in myeloid malignancies","volume":"45","author":"Makishima H","year":"2013","journal-title":"Nat Genet"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1111\/bjh.12491","article-title":"Mutations in SETBP1 are recurrent in myelodysplastic syndromes and often coexist with cytogenetic markers associated with disease progression","volume":"163","author":"Fernandez-Mercado M","year":"2013","journal-title":"Br J Haematol"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1097\/MOH.0000000000000014","article-title":"The molecular genetics of chronic neutrophilic leukaemia: defining a new era in diagnosis and therapy","volume":"21","author":"Elliott MA","year":"2014","journal-title":"Curr Opin Hematol"}],"container-title":["Brazilian Journal of Medical and Biological Research"],"original-title":[],"link":[{"URL":"http:\/\/www.scielo.br\/pdf\/bjmbr\/v48n7\/1414-431X-bjmbr-00-00-4557.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,28]],"date-time":"2025-05-28T02:46:45Z","timestamp":1748400405000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_arttext&pid=S0100-879X2015000700583&tlng=en"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7]]},"references-count":15,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2015,7]]}},"alternative-id":["S0100-879X2015000700583"],"URL":"https:\/\/doi.org\/10.1590\/1414-431x20154557","relation":{},"ISSN":["1414-431X","0100-879X"],"issn-type":[{"type":"electronic","value":"1414-431X"},{"type":"print","value":"0100-879X"}],"subject":[],"published":{"date-parts":[[2015,7]]}}}